Hemp Legalization & Regulatory News for Hemp Businesses

Look like more attention to detail needed at DEA GMR write The much-anticipated hearing for the rescheduling of cannabis was delayed after Chief Administrative Law Judge John Mulrooney issued a preliminary order on Thursday finding fault with the Drug Enforcement Administration’s list of witnesses. First reported by Marijuana Moment, Mulrooney noted that the DEA sent a poorly prepared list

Tilray Brands Inc. is trying to trick investors for a second straight year into increasing its share limit, according to a lawsuit against the Canadian cannabis company. The complaint, filed Thursday, says Tilray is trying to woo shareholders by again making misleading statements about how its corporate charter calls for their votes to be counted. The

The U.S. Drug Enforcement Administration has contacted 25 “designated participants” to testify at a Dec. 2 hearing about marijuana rescheduling, according to documents obtained by MJBizDaily. Before marijuana can be moved from Schedule 1 to Schedule 3 of the Controlled Substances Act, DEA Administrator Anne Milgram ordered that the matter go before an administrative law judge. The

Las Vegas, NV – The International Cannabis Bar Association (INCBA) is excited to announce the 2024 Cannabis Law Sessions at MJBizCon, taking place on Tuesday, December 3, 2024, at the Las Vegas Convention Center. This series of expert-led Continuing Legal Education (CLE) sessions will explore the evolving legal landscape surrounding both cannabis and hemp, offering crucial insights for professionals navigating

A New Zealand medicinal cannabis firm, part-owned by Kind Medical parent Altum International, has been ordered to pay its former technical officer NZ$240,000 after he went without a salary for almost two years. Kariki Pharma failed to pay wages to Alexis Lopez in July 2020 and from November 2020 until he resigned in July 2022,

What’s Your Why with Ricardo Geada We’re so pleased to kick off Season 2 of the What’s Your Why podcast with a brand new sponsor, Botanical Health Dispensary, and an exciting line-up of guests ready to share why medical cannabis matters to them.Our first guest is Ricardo Geada, Director of Lawrence Stephens, where he heads up the

Dr John R. Kelly writes how easing regulatory constraints would facilitate the advance of the scientific evidence underpinning psychedelics and psychedelic therapy The recently formed Trinity College Dublin and Tallaght University Hospital Psychedelic Research Group (TTPRG) is working with several industry partners to conduct large-scale clinical trials of psychedelic therapy for people who suffer from treatment-resistant depression,

Source: https://www.msn.com/en-au/news/australia/the-age-wins-court-battle-over-medicinal-cannabis-investigation/ar-AA1t610r The Federal Court has dismissed a bid by Australia’s largest medicinal cannabis company to force The Age to take down a story revealing allegations the company was operating a legally contentious cannabis referral system. Justice John Snaden dismissed Montu’s application on Tuesday morning and ordered the company to pay The Age’s legal costs. The core issue in the

The Oregon State Bar recently announced Courtney N. Moran, LL.M. as the second-ever recipient of the Leland R. Berger Lifetime Achievement Award! The Oregon State Bar Cannabis and Psychedelics Law Section Leland R. Berger Lifetime Achievement Award was established in 2018 to recognize Lee Berger for his contributions and trailblazing in cannabis law. It is

The maximum sentences for drugs-related crimes will go up considerably if parliament votes in favour of draft legislation published by the cabinet on Monday. The maximum jail term for smuggling hard drugs will be increased from 12 to 16 years, trading hard drugs will go up from eight to 12 years and the possession of a “major